Inicio › Cáncer de endometrio › Ohio › Cincinnati
Ensayos clínicos de Cáncer de endometrio en Cincinnati, OH
14 estudios para Cáncer de endometrio buscan participantes en centros de Cincinnati y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
ReclutandoFase 2
- Good Samaritan Hospital - Cincinnati, Cincinnati
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
ReclutandoFase 3
- University of Cincinnati Medical Center ( Site 5013), Cincinnati
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
ReclutandoFase 3
- University of Cincinnati Medical Center, Cincinnati
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
ReclutandoFase 1
- St. Elizabeth Healthcare, Edgewood · A 8 mi de distancia
A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting
ReclutandoFase 3
- University of Cincinnati Physicians Group, LLC, Cincinnati
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Oncology Hematology Care Primary, Cincinnati
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
ReclutandoFase 3
- Research Site, Cincinnati
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
ReclutandoFase 2
- Research Site, Cincinnati
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ReclutandoFase 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
ReclutandoFase 2
- University of Cincinnati Cancer Center, Cincinnati
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
ReclutandoFase 3
- Research Site, Cincinnati
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
ReclutandoFase 2
- University of Cincinnati Medical Center, Cincinnati
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
ReclutandoFase 1/2
- The Christ Hospital, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Cincinnati
Ensayos de Cáncer de endometrio en otras ciudades
- Houston, TX69 estudios
- New York City, NY54 estudios
- Boston, MA51 estudios
- Arlington, VA41 estudios
- Nashville, TN38 estudios
- Los Angeles, CA35 estudios
- St. Louis, MO29 estudios
- Philadelphia, PA29 estudios
- Oklahoma City, OK28 estudios
- San Antonio, TX27 estudios
- Queens, NY26 estudios
- Dallas, TX25 estudios
Otros estudios en Cincinnati
- Cáncer de pulmón de células no pequeñas31 estudios
- Cáncer (todos los tipos)26 estudios
- Cáncer de seno24 estudios
- Fallo cardíaco22 estudios
- Cáncer metastásico21 estudios
- Cáncer del colon y del recto20 estudios
- Obesidad20 estudios
- Leucemia mielógena aguda20 estudios
- Cáncer de próstata19 estudios
- Cáncer de ovario18 estudios
- Cáncer de pulmón18 estudios
- Mieloma múltiple17 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.